ImmPACT-Bio Competitors and Similar CompaniesClear all
ImmPACT-Bio's competitors and similar companies include JW Therapeutics and Zymeworks.
 ImmPACT-Bio ImmPACT-Bio is a company that develops a chimeric antigen receptor T-cell (CAR-T) therapy. |  Zymeworks Zymeworks is a computational biotechnology company focused on optimizing therapeutic antibodies and other protein-based therapeutics. | ||
Founding Date | Founding Date 2017 | Founding Date 2016 | Founding Date 2003 |
Type | Type Private | Type Private | Type Public |
Tags | |||
Locations | Locations Camarillo, US HQ Rishon Le Tsiyon, IL | Locations CN HQ Suzhou Shi, CN | Locations Vancouver, CA HQ Seattle, US |
Employees | Employees 845% decrease | Employees 106 | Employees 45519% increase |
Funding | |||
Latest funding round | Latest funding round $ 18m (almost 6 years ago) | Latest funding round $ 90m (about 8 years ago) | Latest funding round N/A |
Total funding raised | Total funding raised $ 18m | Total funding raised $ 90m | Total funding raised $ 125.9m |
For sources of this data, please see the company profile
View Company Profiles
JW Therapeutics
HQ
CN
Employees
106
JW Therapeutics is a biotech company focusing on clinical cell therapy technology.
View companyZymeworks
HQ
Vancouver, CA
Employees
455↑ 19% increase
Zymeworks is a computational biotechnology company focused on optimizing therapeutic antibodies and other protein-based therapeutics.
View company